In July, CMS proposed to eliminate the “High Priority” designation and to replace the current outcome or high priority requirement with a requirement to report a MIPS core measure, using a list of 78 designated measures. CMS also proposes to remove the Security Risk Analysis (SRA) measure from the Promoting Interoperability category beginning with the 2027 performance period. These are proposals in the CY 2027 Physician Fee Schedule proposed rule (CMS-1848-P), not final rules. The comment period closed on September 14, 2026, and the final rule (CMS-1848-F) is still pending. As of our review on November 2, 2026, we had not found a final rule posted by CMS.
Nevertheless, these proposals are relevant to all clinicians reporting quality data. Whether you report through traditional MIPS or a MIPS Value Pathway (MVP), your measure set could be affected if the proposals are finalized. Below are details about the proposed changes, who they would affect, and what your billing team can review now. Do not treat any proposed change as a requirement until the final rule confirms it.
Quick Answer
- CMS proposes to remove the “high priority” designation and replace the outcome or high priority requirement with a requirement to report one MIPS core measure, chosen from 78 designated measures.
- Under the proposal, a traditional MIPS clinician would report one core measure as 1 of their 6 quality measures, and an MVP reporter as 1 of their 4. Small practices (15 or fewer clinicians) would be exempt.
- CMS proposes to remove the Security Risk Analysis measure from Promoting Interoperability beginning with the 2027 performance period. HIPAA would still require every covered entity to conduct a security risk analysis.
- None of these changes is final. They are proposals, and the final rule decides which ones take effect.
Proposed vs. Final: Where Things Stand
Use this table to separate what is already final from what is only proposed.
| Item | Status | Dates |
|---|---|---|
| CY 2027 Physician Fee Schedule and QPP rule (CMS-1848-P) | Proposed. Final rule (CMS-1848-F) pending. | Released July 14, 2026. Published in the Federal Register July 16, 2026 (91 FR 43842). Comments closed September 14, 2026. If finalized, effective January 1, 2027. |
| MIPS performance threshold of 75 points | Final (set in a prior rule) | Applies through the 2028 performance period |
| MIPS core measure requirement (replaces outcome or high priority requirement) | Proposed | Beginning with the 2027 performance period / 2029 payment year |
| Removal of the Security Risk Analysis measure | Proposed | Beginning with the 2027 performance period |
| Removal of the ONC Direct Review and ONC-ACB Surveillance attestations | Proposed | Applies beginning with the 2026 performance period |
| Electronic Prior Authorization measure | Final to begin in the 2027 performance period (CMS-0057-F). Proposed change: optional in 2027, required in 2028. | Proposed change would be effective for 2027 and 2028 performance periods |
| New Electronic Prior Authorization for Prescription Drugs measure | Proposed | Required beginning with the 2028 performance period |
| End of traditional MIPS | Proposed | After the 2028 performance period. MVPs only from the 2029 performance period. |
| Three new MVPs (30 total) | Proposed | 2027 performance period |
Why CMS Wants to Retire High Priority Measures
Right now, MIPS clinicians must report at least one outcome measure. If none apply to them, they may report a high priority measure instead. The high priority label currently covers outcome, patient safety, care coordination and several other measure types.
CMS released the proposed rule (CMS-1848-P) on July 14, 2026, and it was published in the Federal Register on July 16, 2026 (91 FR 43842). The comment period closed on September 14, 2026. The final rule determines which proposals survive. CMS is due by statute to publish the final physician fee schedule rule by November 1, but as of our review on November 2, 2026 we had not found one posted. If finalized, the changes would take effect beginning January 1, 2027.
CMS also proposes to end traditional reporting. Under the proposal, traditional MIPS would end after the 2028 performance period. Beginning with the 2029 performance period, MVPs would be the only MIPS reporting option for clinicians outside of a MIPS APM.
That would be a long runway. The proposal gives clinicians until the end of the 2028 performance period to move to an MVP, which leaves time to choose a pathway, build workflows around its measures and, if needed, set up subgroup data collection.
Timing matters because what you report in the 2027 performance period determines your Medicare payment adjustment in 2029.
What's New in the MIPS 2027 Changes
The table shows where today’s rules stand and what CMS proposes. Everything in the right-hand column is proposed, not final.
| Area | Today (current rules) | Proposed (not final) |
|---|---|---|
| Quality requirement | One outcome measure, or a high priority measure if no outcome measure applies | One MIPS core measure (from 78 designated measures). Small practices exempt. |
| High priority label | In use | Proposed for removal |
| Security Risk Analysis measure | Required measure in Promoting Interoperability | Proposed for removal beginning with the 2027 performance period. The HIPAA requirement is unchanged. |
| Electronic Prior Authorization | Final: starts with the 2027 performance period (CMS-0057-F) | Proposed: optional in 2027 (with 10 bonus points available), required beginning with the 2028 performance period |
| Traditional MIPS | Available | Proposed to end after the 2028 performance period |

Quality category
Under the proposal, traditional MIPS clinicians would report one MIPS core measure as 1 of their 6 quality measures. MVP reporters would report one core measure as 1 of their 4, selected from the core measures included in their pathway. CMS proposes designating 78 measures as core measures, and many were previously designated as outcome or high priority measures. If a clinician reports more than one core measure, CMS proposes to use the highest-scoring one to satisfy the requirement.
Small practices (15 or fewer clinicians) would be exempt from the core measure requirement and the related attestation. A clinician with no applicable core measure could attest to that fact and report another quality measure instead.
A clinician who is not in a small practice, and who neither reports a core measure nor files a valid attestation, would score 0 out of 10 points on one of their required quality measures.
The proposal also changes scoring for some measures. Topped-out core measures that are currently capped at 7 points would instead be scored against defined topped-out benchmarks, with a maximum of 10 points, beginning with 2027.
CMS also proposes a smaller inventory: 180 quality measures for the 2027 performance period, with 10 new measures, 20 removals, and substantive changes to 43 existing measures.
CMS proposes three new MVPs, focused on diabetes, hypertension and hospital-based care. That would bring the total to 30. CMS also proposes revising all 27 existing MVPs, including adding core measure selections to each.
Promoting Interoperability category
CMS proposes to remove the Security Risk Analysis measure beginning with the 2027 performance period (2029 payment year). It also proposes to remove two attestations, ONC Direct Review and ONC-ACB Surveillance (ONC is the Office of the National Coordinator for Health Information Technology). Those two removals would apply beginning with the 2026 performance period.
CMS also proposes to make the Electronic Prior Authorization measure optional for the 2027 performance period, with an opportunity to earn 10 bonus points and no penalty for not reporting, and to require it beginning with the 2028 performance period. Reporting would involve requesting a prior authorization electronically through a Prior Authorization API, using certified EHR technology, for at least one medical item or service (drugs excluded). CMS also proposes a new Electronic Prior Authorization for Prescription Drugs measure that would be required beginning with the 2028 performance period.
But what happens to the security work itself? In the proposed rule, CMS reminded MIPS clinicians that they must continue to conduct security risk analysis and risk management to safeguard electronic protected health information, as the Health Insurance Portability and Accountability Act (HIPAA) Security Rule requires. Removing the MIPS measure would not remove that HIPAA obligation.
How the Proposals Hit Providers and Billing Teams
If finalized, the proposals would have the biggest impact on practices that report the same measures every year. A measure you rely on could be removed from MIPS reporting, and a new measure you choose must be supported by your EHR (Electronic Health Record) and registry systems.
CMS already finalized a 75-point performance threshold that applies through the 2028 performance period, and the proposed rule does not change it. If a practice scores zero on a single required measure, it will be much harder to reach that threshold. The result feeds your Final Score, which determines your Medicare payment adjustment for the 2029 payment year. Because revenue is affected by reporting, MIPS belongs in your Healthcare Revenue Cycle Management Services discussions, not only in clinical ones.
How could these changes affect your practice? You may need a new quality measure, a new registry setup, and a review of your Security Risk Analysis schedule.
Billing teams own more of this than they think:
- Evaluating quality measure selection and management of Registry contracts
- Reporting based upon claims that requires clean quality coding provided by either an outside Coding Service for you or your own In-House Coders
- Schedule for Security Risk Analysis
- Workflows within the EHR for prior authorizations
Look at your software as well. CMS proposes to align the Certified Electronic Health Record Technology (CEHRT) definition with changes ONC has proposed to the Health IT Certification Program, beginning with the 2027 performance period. Ask your vendor which CEHRT functionalities will remain.
Does the proposed removal of the Security Risk Analysis measure mean less work? No. The MIPS reporting requirement would go away, but your HIPAA responsibility remains.
What It Means for Patients and Payers
Electronic prior authorization is intended to reduce the time patients wait for treatment and the paperwork physicians complete, by sending requests to payers through FHIR-enabled health information technology (HIT) systems. CMS also proposes an Electronic Prior Authorization for Prescription Drugs measure, which would extend that approach to drug prior authorizations.
The proposed new MVPs for diabetes and hypertension would give clinicians a structured pathway for reporting on the management of chronic conditions such as diabetes and hypertension.
Denial tracking is important because if a provider has trouble getting an approved prior authorization then they may end up having claims denied. Denial tracking can identify common patterns and issues before you lose money.
What Should Your Practice Do Now?
Short answer: compare your current measure list to the 78 proposed core measures now, and run the comparison again when CMS publishes the final rule, because the final list may change.
Next Steps
- Identify all of your 2026 quality measures and flag every outcome or high priority measure that you report.
- Check your reported measures against the 78 proposed core measures in the CMS proposed rule files.
- Contact your EHR vendor and registry to determine whether they will support any measure(s) you select.
- Check whether your practice is a “small” practice (15 or fewer clinicians). If the proposal is finalized, small practices would be exempt from the core measure requirement.
- Schedule your security risk analysis. HIPAA requires one whether or not you participate in MIPS.
- Find out where electronic prior authorization stands within your EHR system.
- Continue to monitor www.CMS.gov for the final rule release, then rerun this comparison.
Sources and Last Reviewed
Last reviewed: November 2, 2026. This article describes proposals in CMS-1848-P. As of that date we had not found a final rule posted by CMS. Check the final rule before making compliance decisions.
- Federal Register: CY 2027 Payment Policies Under the Physician Fee Schedule (CMS-1848-P), 91 FR 43842, July 16, 2026
- CMS: Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule fact sheet
- CMS: Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet
- AMA: 2027 Medicare Physician Payment Schedule and Quality Payment Program Proposed Rule Summary
Frequently Asked Questions
CMS has proposed replacing the high priority requirement with a requirement to report one MIPS core measure from a list of 78, removing the Security Risk Analysis measure, and ending traditional MIPS after the 2028 performance period. These are proposals and are not final.
Not yet. CMS released the proposed rule on July 14, 2026, and the comment period ended on September 14, 2026. The final rule decides which proposals take effect. As of our November 2, 2026 review, we had not found a final rule posted.
Yes. Even if CMS removes the MIPS measure, the HIPAA Security Rule still requires you to conduct a security risk analysis.
Under the proposal, no. Small practices (15 or fewer clinicians) would be exempt from the core measure requirement and the related attestation. This is not final until CMS publishes the final rule.
Changes to rules such as how data is picked, how an Electronic Health Record (EHR) system is configured and how claims are processed will affect how well all three areas work together. Because Human Medical Billing works directly with medical practices to understand the relationships among them, when a new scoring process is put in place it will be less surprising that this occurs at the end of the Performance Period. If you would like someone else review your Measure List, or if you have questions about your billing workflow, please visit our Contact Us page.

Contact Human Medical Billing to schedule a compliance readiness review or learn more about our end-to-end billing and regulatory support services.
